Clinical Trial: Study to Assess Safety and Clinical Responses With Coartem(R) Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria

U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07713602) titled 'Study to Assess Safety and Clinical Responses With Coartem(R) Baby Dispersible Tablets in Paediatric Patients Weighing 2 to =2 kg to <5 kg with uncomplicated malaria due to Plasmodium falciparum or mixed infections under real-world conditions.

Study Start Date: June 18, 2027

Study Type: INTERVENTIONAL

Condition: Malaria

Intervention: DRUG: Coartem(R) Baby

Coartem(R) Baby 2.5mg/30mg oral dispersible tablets to be used at dose of 5mg/60 mg twice per day for 3 days.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Published by HT Digital Content Services with permission from Health Daily Digest....